Xin Sun
Director/Board Member bij SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.
Actieve functies van Xin Sun
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Director/Board Member | 17-09-2020 | - |
Scivita Medical Technology Co., Ltd.
Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Scivita Medical Technology Co., Ltd. operates as a medical device company. It engages in the research and development, manufacturing, and commercialization of optical diagnosis and treatment medical devices. The firm’s products include 3D Visualization system and 4K Urtal HD Endoscope System. The company was founded on October 28, 2016 by Yi Zhang and To Chin and is headquartered in Suzhou, China. | Chairman | 22-06-2021 | - |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Director/Board Member | 17-07-2020 | - |
Loopbaan van Xin Sun
Eerdere bekende functies van Xin Sun
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LUYE PHARMA GROUP LTD. | Director/Board Member | 08-02-2021 | 06-12-2023 |
Affinity Equity Partners (HK) Ltd.
Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Corporate Officer/Principal | - | - |
Opleiding van Xin Sun
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Duke University | Graduate Degree |
Peking University | Undergraduate Degree |
Statistieken
Internationaal
China | 5 |
Verenigde Staten | 3 |
Hongkong | 3 |
Operationeel
Director/Board Member | 3 |
Undergraduate Degree | 2 |
Graduate Degree | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 4 |
Finance | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
LUYE PHARMA GROUP LTD. | Health Technology |
SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Affinity Equity Partners (HK) Ltd.
Affinity Equity Partners (HK) Ltd. Investment ManagersFinance Affinity Equity Partners (HK) Ltd.(Affinity Equity Partners) is an Independent private equity firm founded in 1998 by Kok Yew Tang. Affinity Equity Partners (HK) Ltd. is headquartered in Korea, Australia, New Zealand, Greater China and Southeast Asia.. | Finance |
Scivita Medical Technology Co., Ltd.
Scivita Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Scivita Medical Technology Co., Ltd. operates as a medical device company. It engages in the research and development, manufacturing, and commercialization of optical diagnosis and treatment medical devices. The firm’s products include 3D Visualization system and 4K Urtal HD Endoscope System. The company was founded on October 28, 2016 by Yi Zhang and To Chin and is headquartered in Suzhou, China. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |